Jagged-1 (188-204) TFA
目录号 : GC36361
Jagged-1 (188-204) TFA是Jagged-1（JAG-1）蛋白的一个片段，是神经原性位点Notch同源蛋白1（Notch1）的激动剂。
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Jagged-1 (188-204) TFA is a fragment of the Jagged-1 (JAG-1) protein, an agonist of the neurogenic site Notch homologous protein 1 (Notch1)[1]. Jagged-1 is a Notch ligand that is highly expressed in cultured and primary multiple myeloma (MM) cells[2]. Jagged-1-mediated Notch activation can induce full maturation of human keratinocytes[3]. Jagged-1-mediated Notch activation can promote the differentiation of human limbal epithelial cells[4].
In vitro, treatment of human keratinocytes (KC) with Jagged-1 (188-204) TFA (40μM) for 72h induced the expression of loricrin and involucrin, and induced the cellular redistribution of Notch1, 3, and 4[3]. Jagged-1 (188-204) TFA (50μM) treatment of human pulmonary artery smooth muscle cells (PASMC) for 0-60min enhanced store-operated Ca2+ entry (SOCE) in the cells[5].
References:
[1] Chiappara G, Sciarrino S, Di Sano C, et al. Notch‐1 signaling activation sustains overexpression of interleukin 33 in the epithelium of nasal polyps[J]. Journal of Cellular Physiology, 2019, 234(4): 4582-4596.
[2] Jundt F, Pröbsting K S, Anagnostopoulos I, et al. Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells[J]. Blood, 2004, 103(9): 3511-3515.
[3] Nickoloff B J, Qin J Z, Chaturvedi V, et al. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-κB and PPARγ[J]. Cell Death & Differentiation, 2002, 9(8): 842-855.
[4] González S, Halabi M, Ju D, et al. Role of Jagged1-mediated Notch signaling activation in the differentiation and stratification of the human limbal epithelium[J]. Cells, 2020, 9(9): 1945.
[5] Yamamura H, Yamamura A, Ko E A, et al. Activation of Notch signaling by short-term treatment with Jagged-1 enhances store-operated Ca2+ entry in human pulmonary arterial smooth muscle cells[J]. American Journal of Physiology-Cell Physiology, 2014, 306(9): C871-C878.
Jagged-1 (188-204) TFA是Jagged-1（JAG-1）蛋白的一个片段，是神经原性位点Notch同源蛋白1（Notch1）的激动剂[1]。Jagged-1是一种Notch配体，在培养的和原发性多发性骨髓瘤（MM）细胞中高度表达[2]。Jagged-1介导的Notch激活能够诱导人角质形成细胞完全成熟[3]。Jagged-1介导的Notch激活能够促进人角膜缘上皮细胞的分化[4]。
在体外，Jagged-1 (188-204) TFA（40μM）处理人角质形成细胞（KC）72h，诱导了兜甲蛋白（loricrin）和外皮蛋白（involucrin）表达，诱导了Notch1、3和4的细胞再分布[3]。Jagged-1 (188-204) TFA（50μM）处理人类肺动脉平滑肌细胞（PASMC）0-60min，增强了细胞中钙库操纵的Ca2+内流（SOCE）[5]。
| Cell experiment [1]: | |
Cell lines | Human pulmonary arterial smooth muscle cells (PASMC) |
Preparation Method | In human PASMCs, 10μM cyclopiazonic acid (CPA) was used to passively deplete Ca2+ from the sarcoplasmic reticulum (SR) to induce store-operated Ca2+ entry (SOCE). Cells were treated with 50μM Jagged-1 (188-204) TFA for 0, 5, 10, 30, and 60min, and changes in cytoplasmic free Ca2+ concentration caused by SOCE were recorded. |
Reaction Conditions | 50μM; 0-60min |
Applications | Short-term treatment with Jagged-1 (188-204) TFA enhances store-operated Ca2+ entry (SOCE) in human pulmonary arterial smooth muscle cells (PASMC). |
References: | |
| Cas No. | SDF | ||
| 分子式 | C95H128F3N25O28S3 | 分子量 | 2221.42 |
| 溶解度 | Water: 50 mg/mL (22.51 mM) | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 0.4502 mL | 2.2508 mL | 4.5016 mL |
| 5 mM | 0.09 mL | 0.4502 mL | 0.9003 mL |
| 10 mM | 0.045 mL | 0.2251 mL | 0.4502 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet